Recent advances in molecular imaging of atherosclerotic plaques and thrombosis.
暂无分享,去创建一个
Mingyuan Gao | Yu Qin | Thomas P Davis | Yu Qin | T. P. Davis | Mingyuan Gao | C. Hagemeyer | Ruirui Qiao | Ruirui Qiao | Christoph E Hagemeyer | Yuhuan Li | Xumin Huang | Yuhuan Li | Xumin Huang
[1] Y. Magata,et al. Macrophage-targeted, enzyme-triggered fluorescence switch-on system for detection of embolism-vulnerable atherosclerotic plaques. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[2] P. Weissberg,et al. Molecular and metabolic imaging of atherosclerosis. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] Qiwen Chen,et al. Recent advances in different modal imaging-guided photothermal therapy. , 2016, Biomaterials.
[4] E M Sevick-Muraca,et al. A review of performance of near-infrared fluorescence imaging devices used in clinical studies. , 2015, The British journal of radiology.
[5] Matthew Tirrell,et al. Active targeting of early and mid-stage atherosclerotic plaques using self-assembled peptide amphiphile micelles. , 2014, Biomaterials.
[6] Gareth Loy,et al. 7T MR of intracranial pathology: Preliminary observations and comparisons to 3T and 1.5T , 2016, NeuroImage.
[7] D. Celermajer. Noninvasive detection of atherosclerosis. , 1998, The New England journal of medicine.
[8] J. Zwanenburg,et al. MRI of the carotid artery at 7 Tesla: Quantitative comparison with 3 Tesla , 2015, Journal of magnetic resonance imaging : JMRI.
[9] Hao Hong,et al. Positron Emission Tomography Imaging of Atherosclerosis , 2013, Theranostics.
[10] Hongki Yoo,et al. Intravascular optical imaging of high-risk plaques in vivo by targeting macrophage mannose receptors , 2016, Scientific Reports.
[11] C. H. J. Choi,et al. Recent Advances in Managing Atherosclerosis via Nanomedicine. , 2018, Small.
[12] Zahi A. Fayad,et al. Imaging of atherosclerotic cardiovascular disease , 2008, Nature.
[13] Hamidreza Arandiyan,et al. Lanthanide‐Doped Upconversion Nanoparticles: Emerging Intelligent Light‐Activated Drug Delivery Systems , 2016, Advanced science.
[14] S. Wickline,et al. Thrombin‐inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis , 2011, Journal of thrombosis and haemostasis : JTH.
[15] J. Zamorano,et al. Non-Invasive Detection of Extracellular Matrix Metalloproteinase Inducer EMMPRIN, a New Therapeutic Target against Atherosclerosis, Inhibited by Endothelial Nitric Oxide , 2018, International journal of molecular sciences.
[16] S. Harris,et al. OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient mice , 2012, Journal of Lipid Research.
[17] J. Bulte,et al. Fluorine (19F) MRS and MRI in biomedicine , 2011, NMR in biomedicine.
[18] J. Gillard,et al. Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[19] Suresh Gadde,et al. Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis. , 2016, ACS nano.
[20] J. Michel,et al. Functional imaging of atherosclerosis to advance vascular biology. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[21] Yu-Chen Chen,et al. In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[22] Wei Feng,et al. Biodistribution of sub-10 nm PEG-modified radioactive/upconversion nanoparticles. , 2013, Biomaterials.
[23] S. Dhar,et al. Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis , 2013, Proceedings of the National Academy of Sciences.
[24] Y. Urano,et al. Design and synthesis of fluorescent probes for selective detection of highly reactive oxygen species in mitochondria of living cells. , 2007, Journal of the American Chemical Society.
[25] N. Hayashi,et al. Enhancement of the intracranial arterial wall at MR imaging: relationship to cerebral atherosclerosis. , 1995, Radiology.
[26] K König,et al. Clinical two‐photon microendoscopy , 2007, Microscopy research and technique.
[27] J. Frangioni. In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.
[28] Steven B. Feinstein,et al. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? , 2007, Vascular medicine.
[29] Zhuang Liu,et al. Carbon nanotubes for biomedical imaging: the recent advances. , 2013, Advanced drug delivery reviews.
[30] G. Lippi,et al. Arterial thrombus formation in cardiovascular disease , 2011, Nature Reviews Cardiology.
[31] Kai Yang,et al. Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy. , 2011, Angewandte Chemie.
[32] Qingsong Mei,et al. Near-Infrared Excited Orthogonal Emissive Upconversion Nanoparticles for Imaging-Guided On-Demand Therapy. , 2019, ACS nano.
[33] A. Algra,et al. Intracranial Vessel Wall Lesions on 7T MRI (Magnetic Resonance Imaging): Occurrence and Vascular Risk Factors The SMART-MR Study , 2019, Stroke.
[34] Anna Nowogrodzki,et al. The world’s strongest MRI machines are pushing human imaging to new limits , 2018, Nature.
[35] Hisataka Kobayashi,et al. Dendrimer-based contrast agents for molecular imaging. , 2008, Current topics in medicinal chemistry.
[36] 19F molecular MR imaging for detection of brain tumor angiogenesis: in vivo validation using targeted PFOB nanoparticles , 2012, Angiogenesis.
[37] Ralph Weissleder,et al. Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor , 2007, Circulation.
[38] R. Forsythe,et al. Emerging techniques in atherosclerosis imaging , 2019, The British journal of radiology.
[39] H. Kai. Novel non‐invasive approach for visualizing inflamed atherosclerotic plaques using fluorodeoxyglucose‐positron emission tomography , 2010, Geriatrics & gerontology international.
[40] E. V. van Beek,et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. , 2012, Journal of the American College of Cardiology.
[41] Wei Li,et al. In Vivo Targeting and Imaging of Atherosclerosis Using Multifunctional Virus-Like Particles of Simian Virus 40. , 2016, Nano letters.
[42] Chun Yuan,et al. MRI of carotid atherosclerosis: clinical implications and future directions , 2010, Nature Reviews Cardiology.
[43] Jie Shen,et al. Lanthanide-doped upconverting luminescent nanoparticle platforms for optical imaging-guided drug delivery and therapy. , 2013, Advanced drug delivery reviews.
[44] Hyungwoo Kim,et al. Recent Progress on Near-Infrared Photoacoustic Imaging: Imaging Modality and Organic Semiconducting Agents , 2019, Polymers.
[45] Eric D. Pressly,et al. Assessment of Targeted Nanoparticle Assemblies for Atherosclerosis Imaging with Positron Emission Tomography and Potential for Clinical Translation. , 2019, ACS applied materials & interfaces.
[46] A. Nederveen,et al. Emerging Magnetic Resonance Imaging Techniques for Atherosclerosis Imaging. , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[47] J. Bodle,et al. High-Resolution Magnetic Resonance Imaging: An Emerging Tool for Evaluating Intracranial Arterial Disease , 2013, Stroke.
[48] G. Hansson. Immune and inflammatory mechanisms in the development of atherosclerosis. , 1993, British heart journal.
[49] F. Cao,et al. Optical/MRI dual-modality imaging of M1 macrophage polarization in atherosclerotic plaque with MARCO-targeted upconversion luminescence probe. , 2019, Biomaterials.
[50] Chih-Ming Ho,et al. Monocyte recruitment to endothelial cells in response to oscillatory shear stress , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[51] Giorgio Russolillo,et al. Partial least squares algorithms and methods , 2013 .
[52] M. Mollenhauer,et al. Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice. , 2016, International journal of cardiology.
[53] Vasilis Ntziachristos,et al. Looking and listening to light: the evolution of whole-body photonic imaging , 2005, Nature Biotechnology.
[54] Z. Fayad,et al. Fractionated feridex and positive contrast: In vivo MR imaging of atherosclerosis , 2008, Magnetic resonance in medicine.
[55] B. Tang,et al. A LRET-based luminescence nanoprobe for in situ imaging of CD36 activation and CD36-oxLDL binding in atherogenesis. , 2019, Analytical chemistry.
[56] Xing-jie Liang,et al. Biomedical nanomaterials for imaging-guided cancer therapy. , 2012, Nanoscale.
[57] F. Caruso,et al. Low-Fouling and Biodegradable Protein-Based Particles for Thrombus Imaging. , 2018, ACS nano.
[58] M. Biran,et al. Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[59] R. Kanwar,et al. Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents , 2016, Journal of Nanobiotechnology.
[60] Christopher Poon,et al. Gadolinium-Functionalized Peptide Amphiphile Micelles for Multimodal Imaging of Atherosclerotic Lesions , 2016, ACS omega.
[61] Erkki Ruoslahti,et al. Targeting atherosclerosis by using modular, multifunctional micelles , 2009, Proceedings of the National Academy of Sciences.
[62] Z. Fayad,et al. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. , 2008, Small.
[63] P. Barthélémy,et al. Iron oxide core oil-in-water nanoemulsion as tracer for atherosclerosis MPI and MRI imaging. , 2017, International journal of pharmaceutics.
[64] M. Ladd,et al. Wall Contrast Enhancement of Thrombosed Intracranial Aneurysms at 7T MRI , 2019, American Journal of Neuroradiology.
[65] Sarah E Bohndiek,et al. Contrast agents for molecular photoacoustic imaging , 2016, Nature Methods.
[66] Rodolfo Miranda,et al. Engineering Iron Oxide Nanoparticles for Clinical Settings , 2014, Nanobiomedicine.
[67] J. Westra,et al. Feasibility of [18F]-RGD for ex vivo imaging of atherosclerosis in detection of αvβ3 integrin expression , 2015, Journal of Nuclear Cardiology.
[68] D. Berman,et al. Coronary Atherosclerosis T1-Weighed Characterization With Integrated Anatomical Reference: Comparison With High-Risk Plaque Features Detected by Invasive Coronary Imaging. , 2017, JACC. Cardiovascular imaging.
[69] S. Wickline,et al. Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents. , 2015, Nanomedicine.
[70] Mathias Hoehn,et al. Labeling cells for in vivo tracking using (19)F MRI. , 2012, Biomaterials.
[71] P. Doevendans,et al. Recent developments and new perspectives on imaging of atherosclerotic plaque: role of anatomical, cellular and molecular MRI Part I and II , 2009, The International Journal of Cardiovascular Imaging.
[72] L. Gutiérrez,et al. Unambiguous detection of atherosclerosis using bioorthogonal nanomaterials. , 2019, Nanomedicine : nanotechnology, biology, and medicine.
[73] Kai Jiang,et al. Dual-Modal Magnetic Resonance and Fluorescence Imaging of Atherosclerotic Plaques in Vivo Using VCAM-1 Targeted Tobacco Mosaic Virus , 2014, Nano letters.
[74] Patrick J. Gaffney,et al. Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles , 2004 .
[75] R. Willette,et al. Differential uptake of ferumoxtran‐10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: Critical determinants of atherosclerotic plaque labeling , 2005, Journal of magnetic resonance imaging : JMRI.
[76] Jie Tian,et al. Molecular Imaging of Vulnerable Atherosclerotic Plaques in Vivo with Osteopontin-Specific Upconversion Nanoprobes. , 2017, ACS nano.
[77] K. Moore,et al. Macrophages in the Pathogenesis of Atherosclerosis , 2011, Cell.
[78] Z. Fayad,et al. Imaging and Nanomedicine in Inflammatory Atherosclerosis , 2014, Science Translational Medicine.
[79] E. Bramucci,et al. Thrombogenic potential of human coronary atherosclerotic plaques. , 2001, Blood.
[80] René M. Botnar,et al. Novel Approach for In Vivo Detection of Vulnerable Coronary Plaques Using Molecular 3-T CMR Imaging With an Albumin-Binding Probe. , 2018, JACC. Cardiovascular imaging.
[81] Jinming Hu,et al. Functionalization of NaGdF4 nanoparticles with a dibromomaleimide-terminated polymer for MR/optical imaging of thrombosis , 2020 .
[82] H. Saji,et al. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green. , 2018, Atherosclerosis.
[83] T. Hyeon,et al. Nanostructured T1 MRI contrast agents , 2009 .
[84] Po-Hsiang Tsui,et al. Discrimination between Newly Formed and Aged Thrombi Using Empirical Mode Decomposition of Ultrasound B-Scan Image , 2015, BioMed research international.
[85] S. Wickline,et al. Molecular imaging by cardiovascular MR. , 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[86] Erling Falk,et al. Update on acute coronary syndromes: the pathologists' view. , 2013, European heart journal.
[87] Gerald Stübiger,et al. Gold nanoparticle-conjugated anti-oxidized low-density lipoprotein antibodies for targeted lipidomics of oxidative stress biomarkers. , 2013, Analytical chemistry.
[88] A. Malik,et al. Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.
[89] Konstantin Sokolov,et al. Plasmonic intravascular photoacoustic imaging for detection of macrophages in atherosclerotic plaques. , 2009, Nano letters.
[90] A. Speghini,et al. Optical spectroscopy of nanocrystalline cubic Y2O3:Er3+ obtained by combustion synthesis , 2000 .
[91] Shai Ashkenazi,et al. Photoacoustic lifetime imaging of dissolved oxygen using methylene blue. , 2010, Journal of biomedical optics.
[92] Tianfu Wang,et al. Recent Advances in Photoacoustic Imaging for Deep-Tissue Biomedical Applications , 2016, Theranostics.
[93] L. Ngo,et al. The FLARE™ Intraoperative Near-Infrared Fluorescence Imaging System: A First-in-Human Clinical Trial in Breast Cancer Sentinel Lymph Node Mapping , 2009, Annals of Surgical Oncology.
[94] Vasilis Ntziachristos,et al. A macrophage uptaking near-infrared chemical probe CDnir7 for in vivo imaging of inflammation. , 2014, Chemical communications.
[95] C. Bode,et al. Targeting Ligand-Induced Binding Sites on GPIIb/IIIa via Single-Chain Antibody Allows Effective Anticoagulation Without Bleeding Time Prolongation , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[96] K. Seung,et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. , 2002, Journal of the American College of Cardiology.
[97] B. Zhang,et al. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe. , 2019, Acta biomaterialia.
[98] Stanislav Emelianov,et al. Methodical study on plaque characterization using integrated vascular ultrasound, strain and spectroscopic photoacoustic imaging , 2011, BiOS.
[99] Shobha Ghosh,et al. Development of mannose functionalized dendrimeric nanoparticles for targeted delivery to macrophages: use of this platform to modulate atherosclerosis , 2017, Translational research : the journal of laboratory and clinical medicine.
[100] Megan C. Garland,et al. A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application. , 2016, Cell chemical biology.
[101] P. Choyke,et al. New strategies for fluorescent probe design in medical diagnostic imaging. , 2010, Chemical reviews.
[102] J. Leor,et al. E‐selectin‐targeted copolymer reduces atherosclerotic lesions, adverse cardiac remodeling, and dysfunction , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[103] Susan Hua,et al. Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization , 2018, Front. Pharmacol..
[104] Vasilis Ntziachristos,et al. Optoacoustic Imaging of Naphthalocyanine: Potential for Contrast Enhancement and Therapy Monitoring , 2015, The Journal of Nuclear Medicine.
[105] Wanwan Li,et al. Gold nanoparticles for photoacoustic imaging. , 2015, Nanomedicine.
[106] K. Kikuchi,et al. Perfluorocarbon‐Based 19F MRI Nanoprobes for In Vivo Multicolor Imaging , 2018, Angewandte Chemie.
[107] Hongcheng Shi,et al. Detection of vulnerable atherosclerosis plaques with a dual-modal single-photon-emission computed tomography/magnetic resonance imaging probe targeting apoptotic macrophages. , 2015, ACS applied materials & interfaces.
[108] H. Yang,et al. Multifunctional and Redox-Responsive Self-Assembled Magnetic Nanovectors for Protein Delivery and Dual-Modal Imaging. , 2017, ACS applied materials & interfaces.
[109] C. McNamara,et al. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[110] Hak Soo Choi,et al. Cartilage-Specific Near-Infrared Fluorophores for Biomedical Imaging. , 2015, Angewandte Chemie.
[111] Ralph Weissleder,et al. Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic Plaques , 2013, Circulation research.
[112] Ralph Weissleder,et al. Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis , 2008, Circulation.
[113] Da Xing,et al. Fluorescence Quenching Nanoprobes Dedicated to In Vivo Photoacoustic Imaging and High-Efficient Tumor Therapy in Deep-Seated Tissue. , 2015, Small.
[114] Wenpei Fan,et al. On The Latest Three‐Stage Development of Nanomedicines based on Upconversion Nanoparticles , 2016, Advanced materials.
[115] Kai Jiang,et al. Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging. , 2015, Journal of materials chemistry. B.
[116] Kwangmeyung Kim,et al. Comparison of in vivo targeting ability between cRGD and collagen‐targeting peptide conjugated nano‐carriers for atherosclerosis , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[117] S. Jackson. Arterial thrombosis—insidious, unpredictable and deadly , 2011, Nature Medicine.
[118] A. Bongers,et al. Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque , 2018, European heart journal.
[119] Paul Schoenhagen,et al. Emergence of targeted molecular imaging in atherosclerotic cardiovascular disease , 2009, Expert review of cardiovascular therapy.
[120] C. Weber,et al. Atherosclerosis: current pathogenesis and therapeutic options , 2011, Nature Medicine.
[121] Jian Zhang,et al. Inflammation-targeted gold nanorods for intravascular photoacoustic imaging detection of matrix metalloproteinase-2 (MMP2) in atherosclerotic plaques. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[122] J. Egido,et al. Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI , 2015, Scientific Reports.
[123] J. Rudd,et al. PET imaging of inflammation in atherosclerosis , 2014, Nature Reviews Cardiology.
[124] D. Zhao,et al. Lab on upconversion nanoparticles: optical properties and applications engineering via designed nanostructure. , 2015, Chemical Society reviews.
[125] V. Fuster,et al. Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque , 2001, Circulation research.
[126] Ping Gong,et al. Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy. , 2014, ACS nano.
[127] S. Caruthers,et al. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles , 2007, Journal of magnetic resonance imaging : JMRI.
[128] J. G. Solé,et al. 1.3 μm emitting SrF2:Nd3+ nanoparticles for high contrast in vivo imaging in the second biological window , 2015, Nano Research.
[129] E. Tremoli,et al. Tissue factor in atherosclerosis. , 1999, Atherosclerosis.
[130] B. Delman,et al. Emerging Use of Ultra-High-Field 7T MRI in the Study of Intracranial Vascularity: State of the Field and Future Directions , 2019, American Journal of Neuroradiology.
[131] M. Sung,et al. Enhancement of the photostability and retention time of indocyanine green in sentinel lymph node mapping by anionic polyelectrolytes. , 2011, Biomaterials.
[132] Yao Sun,et al. Multimodality Molecular Imaging of Cardiovascular Disease Based on Nanoprobes , 2018, Cellular Physiology and Biochemistry.
[133] Mark J Post,et al. Nanoparticles for optical molecular imaging of atherosclerosis. , 2009, Small.
[134] Paul C. Beard. Photoacoustic imaging of blood vessel equivalent phantoms , 2002, SPIE BiOS.
[135] E. Ratchford,et al. Usefulness of coronary and carotid imaging rather than traditional atherosclerotic risk factors to identify firefighters at increased risk for cardiovascular disease. , 2014, The American journal of cardiology.
[136] R. Schreiber,et al. Programmable nanoparticle functionalization for in vivo targeting , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[137] Matthew Tirrell,et al. Monocyte‐Targeting Supramolecular Micellar Assemblies: A Molecular Diagnostic Tool for Atherosclerosis , 2015, Advanced healthcare materials.
[138] Y. Lei,et al. Nanoparticle targeting to diseased vasculature for imaging and therapy. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[139] V. Fuster,et al. Early identification of atherosclerotic disease by noninvasive imaging , 2010, Nature Reviews Cardiology.
[140] P. Matthews,et al. Near Infrared Fluorescence (NIRF) Molecular Imaging of Oxidized LDL with an Autoantibody in Experimental Atherosclerosis , 2016, Scientific Reports.
[141] B. Ludewig,et al. The in and out of monocytes in atherosclerotic plaques: Balancing inflammation through migration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[142] Paulino Vacas-Jacques,et al. Clinical Characterization of Coronary Atherosclerosis With Dual-Modality OCT and Near-Infrared Autofluorescence Imaging. , 2016, JACC. Cardiovascular imaging.
[143] J. Fujimoto. Optical coherence tomography for ultrahigh resolution in vivo imaging , 2003, Nature Biotechnology.
[144] J. Zwanenburg,et al. Clinical applications of 7 T MRI in the brain. , 2013, European journal of radiology.
[145] Wei Wang,et al. Recent developments in multimodality fluorescence imaging probes , 2018, Acta pharmaceutica Sinica. B.
[146] R. Krams,et al. Molecular MR imaging of collagen in mouse atherosclerosis by using paramagnetic CNA35 micelles , 2012 .
[147] Hsiao-Ying Wey,et al. Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease , 2017, Nature Communications.
[148] Feng Cao,et al. In vivo MR and Fluorescence Dual-modality Imaging of Atherosclerosis Characteristics in Mice Using Profilin-1 Targeted Magnetic Nanoparticles , 2016, Theranostics.
[149] R. Kruger,et al. Photoacoustic ultrasound (PAUS)--reconstruction tomography. , 1995, Medical physics.
[150] E. Warburton,et al. Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography , 2015, Nature Communications.
[151] V. Bulmus,et al. The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications , 2010 .
[152] K. Ley,et al. Immune and inflammatory mechanisms of atherosclerosis (*). , 2009, Annual review of immunology.
[153] Joseph J. Richardson,et al. Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake. , 2019, Biomacromolecules.
[154] R. Virmani,et al. Mechanisms of Plaque Formation and Rupture , 2014 .
[155] Ralph Weissleder,et al. Enzyme-Sensitive Magnetic Resonance Imaging Targeting Myeloperoxidase Identifies Active Inflammation in Experimental Rabbit Atherosclerotic Plaques , 2009, Circulation.
[156] M. E. Kooi,et al. Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.
[157] Lihong V. Wang,et al. In vivo photoacoustic tomography of chemicals: high-resolution functional and molecular optical imaging at new depths. , 2010, Chemical reviews.
[158] T. Villines,et al. Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events , 2015, Current Cardiovascular Imaging Reports.
[159] T. Beyer,et al. Quantitative assessment of atherosclerotic plaques on 18F-FDG PET/MRI: comparison with a PET/CT hybrid system , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[160] Liangping Zhou,et al. Ultrasmall NaGdF4 Nanodots for Efficient MR Angiography and Atherosclerotic Plaque Imaging , 2014, Advanced materials.
[161] L. Boussel,et al. Clinical and Histological Significance of Gadolinium Enhancement in Carotid Atherosclerotic Plaque , 2012, Stroke.
[162] Gijs van Soest,et al. Photoacoustic imaging of human coronary atherosclerosis in two spectral bands , 2013, Photoacoustics.
[163] Chun Yuan,et al. In Vivo Quantitative Measurement of Intact Fibrous Cap and Lipid-Rich Necrotic Core Size in Atherosclerotic Carotid Plaque: Comparison of High-Resolution, Contrast-Enhanced Magnetic Resonance Imaging and Histology , 2005, Circulation.
[164] B. Tang,et al. Copper sulfide nanoparticles as a photothermal switch for TRPV1 signaling to attenuate atherosclerosis , 2018, Nature Communications.
[165] Lynne McCormick,et al. Whole body cardiovascular magnetic resonance imaging to stratify symptomatic and asymptomatic atherosclerotic burden in patients with isolated cardiovascular disease , 2016, BMC Medical Imaging.
[166] S A Wickline,et al. Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.
[167] A. Nederveen,et al. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation. , 2017, Atherosclerosis.
[168] Zhuxian Zhou,et al. Gadolinium-based contrast agents for magnetic resonance cancer imaging. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[169] N. Tamaki,et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[170] Martin J Graves,et al. In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI , 2004, Stroke.
[171] A. Loewy,et al. Osteopontin Transcription in Aortic Vascular Smooth Muscle Cells Is Controlled by Glucose-regulated Upstream Stimulatory Factor and Activator Protein-1 Activities* , 2002, The Journal of Biological Chemistry.
[172] T. Derlin,et al. Anti-MYC-associated zinc finger protein antibodies are associated with inflammatory atherosclerotic lesions on 18F-fluorodeoxyglucose positron emission tomography. , 2017, Atherosclerosis.
[173] R. Weissleder,et al. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.
[174] Jie Tian,et al. MRI/optical dual-modality imaging of vulnerable atherosclerotic plaque with an osteopontin-targeted probe based on Fe3O4 nanoparticles. , 2017, Biomaterials.
[175] Juan Li,et al. Plant Polyphenol-Assisted Green Synthesis of Hollow CoPt Alloy Nanoparticles for Dual-Modality Imaging Guided Photothermal Therapy. , 2016, Small.
[176] V. Fuster,et al. MRI and Characterization of Atherosclerotic Plaque: Emerging Applications and Molecular Imaging , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[177] R. Gropler,et al. Visualization of Monocytic Cells in Regressing Atherosclerotic Plaques by Intravital 2-Photon and Positron Emission Tomography–Based Imaging—Brief Report , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[178] E. Berg,et al. Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectin. , 1998, Journal of immunology.
[179] Huang-Hao Yang,et al. Co9Se8 Nanoplates as a New Theranostic Platform for Photoacoustic/Magnetic Resonance Dual‐Modal‐Imaging‐Guided Chemo‐Photothermal Combination Therapy , 2015, Advanced materials.
[180] David Saloner,et al. High resolution imaging of the intracranial vessel wall at 3 and 7 T using 3D fast spin echo MRI , 2016, Magnetic Resonance Materials in Physics, Biology and Medicine.
[181] P. Beard. Biomedical photoacoustic imaging , 2011, Interface Focus.
[182] H. Jo,et al. Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE–/– Mice , 2015, ACS nano.
[183] Peng Chen,et al. Organic Dye Based Nanoparticles for Cancer Phototheranostics. , 2018, Small.
[184] Z. Fayad,et al. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques. , 2010, Bioconjugate chemistry.
[185] Zahi A Fayad,et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography , 2007, Nature Medicine.
[186] J. Hamilton,et al. In vivo Detection of Vulnerable Atherosclerotic Plaque by MRI in a Rabbit Model , 2010, Circulation. Cardiovascular imaging.
[187] J. Ruíz-Cabello,et al. Surface-Functionalized Nanoparticles by Olefin Metathesis: A Chemoselective Approach for In Vivo Characterization of Atherosclerosis Plaque. , 2015, Chemistry.
[188] Fabien Hyafil,et al. Ferumoxtran-10–Enhanced MRI of the Hypercholesterolemic Rabbit Aorta: Relationship Between Signal Loss and Macrophage Infiltration , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[189] Ming Wu,et al. Lipid micelles packaged with semiconducting polymer dots as simultaneous MRI/photoacoustic imaging and photodynamic/photothermal dual-modal therapeutic agents for liver cancer. , 2016, Journal of materials chemistry. B.
[190] M. Olschewski,et al. Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis , 2008, Circulation.
[191] P. Serruys,et al. Invasive or non-invasive imaging for detecting high-risk coronary lesions? , 2017, Expert review of cardiovascular therapy.
[192] R. Weissleder,et al. An azulene dimer as a near-infrared quencher. , 2002, Angewandte Chemie.
[193] Megan C. Garland,et al. Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation , 2016, The Journal of Nuclear Medicine.
[194] P. Libby,et al. Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging , 2017, Circulation. Cardiovascular imaging.
[195] Guillermo J Tearney,et al. Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green. , 2016, JACC. Cardiovascular imaging.
[196] Samir Mitragotri,et al. Platelet-like Nanoparticles: Mimicking Shape, Flexibility, and Surface Biology of Platelets To Target Vascular Injuries , 2014, ACS nano.
[197] Vasilis Ntziachristos,et al. Cardiovascular optoacoustics: From mice to men – A review , 2019, Photoacoustics.
[198] Ralph Weissleder,et al. Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.
[199] Qiangbin Wang,et al. A novel photoacoustic nanoprobe of ICG@PEG-Ag2S for atherosclerosis targeting and imaging in vivo. , 2016, Nanoscale.
[200] P. Little,et al. Non-invasive imaging techniques for the differentiation of acute and chronic thrombosis. , 2019, Thrombosis research.
[201] H. Lee,et al. Use of contrast enhancement and high-resolution 3D black-blood MRI to identify inflammation in atherosclerosis. , 2010, JACC. Cardiovascular imaging.
[202] Jianhua Hao,et al. Simultaneous synthesis and functionalization of water-soluble up-conversion nanoparticles for in-vitro cell and nude mouse imaging. , 2011, Nanoscale.
[203] Z. Fayad,et al. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis , 2017, ACS nano.
[204] R. Dixon,et al. Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1 , 2018, Scientific Reports.
[205] S. Emelianov,et al. Intravascular photoacoustic imaging using an IVUS imaging catheter , 2007, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[206] S. Emelianov,et al. Detection of lipid in atherosclerotic vessels using ultrasound-guided spectroscopic intravascular photoacoustic imaging , 2010, Optics express.
[207] J. Cheon,et al. Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy. , 2015, Chemical reviews.
[208] J. Debatin,et al. Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.
[209] S. Gambhir,et al. Light in and sound out: emerging translational strategies for photoacoustic imaging. , 2014, Cancer research.
[210] Mark J. Miller,et al. Quantifying progression and regression of thrombotic risk in experimental atherosclerosis , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[211] Sébastien Lecommandoux,et al. Photo‐triggered polymer nanomedicines: From molecular mechanisms to therapeutic applications , 2019, Advanced drug delivery reviews.
[212] W. Ouwehand,et al. Detection of Atherosclerotic Inflammation by 68Ga-DOTATATE PET Compared to [18F]FDG PET Imaging , 2017, Journal of the American College of Cardiology.
[213] Philippe Robert,et al. Comparison of Different Types of Blood Pool Agents (P792, MS325, USPIO) in a Rabbit MR Angiography-like Protocol , 2003, Investigative radiology.
[214] Da Xing,et al. Gadolinium(III)-gold nanorods for MRI and photoacoustic imaging dual-modality detection of macrophages in atherosclerotic inflammation. , 2013, Nanomedicine.
[215] Stanislav Y. Emelianov,et al. Biomedical Applications of Photoacoustic Imaging with Exogenous Contrast Agents , 2011, Annals of Biomedical Engineering.
[216] Xiaolong Liu,et al. Magnetite nanocluster@poly(dopamine)-PEG@ indocyanine green nanobead with magnetic field-targeting enhanced MR imaging and photothermal therapy in vivo. , 2016, Colloids and surfaces. B, Biointerfaces.
[217] L. Velázquez-Villegas,et al. Nutrition and Atherosclerosis. , 2015, Archives of medical research.
[218] Valentin Fuster,et al. Imaging of atherosclerosis: magnetic resonance imaging. , 2011, European heart journal.
[219] Wei Feng,et al. Polyphosphoric acid capping radioactive/upconverting NaLuF4:Yb,Tm,153Sm nanoparticles for blood pool imaging in vivo. , 2013, Biomaterials.
[220] Jiwon Kim,et al. Thrombin-activatable fluorescent peptide incorporated gold nanoparticles for dual optical/computed tomography thrombus imaging. , 2018, Biomaterials.
[221] B. Wall,et al. Rare-earth-doped biological composites as in vivo shortwave infrared reporters , 2013, Nature Communications.
[222] Michael Scott,et al. Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents , 2011, PloS one.
[223] Rolf Schubert,et al. Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half‐lives and sensitivity , 2014, NMR in biomedicine.
[224] Guosong Hong,et al. Multifunctional in vivo vascular imaging using near-infrared II fluorescence , 2012, Nature Medicine.
[225] Kai Chen,et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. , 2010, Biomaterials.
[226] M. Stuber,et al. Fluorine MR Imaging of Inflammation in Atherosclerotic Plaque in Vivo. , 2015, Radiology.
[227] W. Mulder,et al. Targeting myeloperoxidase in inflammatory atherosclerosis. , 2018, European heart journal.